These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3262206)

  • 1. Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant.
    Reinhard JF; Daniels AJ; Viveros OH
    Neurosci Lett; 1988 Aug; 90(3):349-53. PubMed ID: 3262206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse.
    Sundström E; Jonsson G
    Eur J Pharmacol; 1985 Apr; 110(3):293-9. PubMed ID: 3874083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Pileblad E; Carlsson A
    Pharmacol Toxicol; 1988 Apr; 62(4):213-22. PubMed ID: 3260379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury.
    Reinhard JF; Miller DB; O'Callaghan JP
    Neurosci Lett; 1988 Dec; 95(1-3):246-51. PubMed ID: 3265770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.
    Reinhard JF; Diliberto EJ; Viveros OH; Daniels AJ
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8160-4. PubMed ID: 2891137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP.
    Melamed E; Rosenthal J; Cohen O; Globus M; Uzzan A
    Eur J Pharmacol; 1985 Oct; 116(1-2):179-81. PubMed ID: 3876943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.
    Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP
    J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the reserpine-sensitive storage in vivo of 1-methyl-4-phenylpyridinium in rats and mice may explain differences in catecholamine toxicity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Russo SM; Daniels AJ; Viveros OH; Reinhard JF
    Neurotoxicol Teratol; 1994; 16(3):277-81. PubMed ID: 7935261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP.
    Hemrick-Luecke SK; Robertson DW; Krushinski JH; Fuller RW
    Life Sci; 1992; 50(8):573-82. PubMed ID: 1736028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of dopaminergic toxicity of MPTP in mice by phenylethylamine, a specific substrate of type B monoamine oxidase.
    Melamed E; Youdim MB
    Br J Pharmacol; 1985 Nov; 86(3):529-31. PubMed ID: 3877535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons.
    German DC; Liang CL; Manaye KF; Lane K; Sonsalla PK
    Neuroscience; 2000; 101(4):1063-9. PubMed ID: 11113355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse.
    Hallman H; Lange J; Olson L; Strömberg I; Jonsson G
    J Neurochem; 1985 Jan; 44(1):117-27. PubMed ID: 3880581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP+) in the rat.
    Algeri S; Ambrosio S; Garofalo P; Gerli P
    Eur J Pharmacol; 1987 Sep; 141(2):309-12. PubMed ID: 3500067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.
    Irwin I; Langston JW; DeLanney LE
    Life Sci; 1987 Feb; 40(8):731-40. PubMed ID: 3492652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice.
    Fuller RW; Hemrick-Luecke SK
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):687-90. PubMed ID: 3878976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
    Fuller RW; Hemrick-Luecke SK; Robertson DW
    Biochem Pharmacol; 1988 Sep; 37(17):3343-7. PubMed ID: 3135812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of intranasal infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) upon catecholamine concentrations within olfactory bulbs and corpus striatum of male mice.
    Dluzen DE; Kefalas G
    Brain Res; 1996 Nov; 741(1-2):215-9. PubMed ID: 9001725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice.
    Melamed E; Pikarski E; Goldberg A; Rosenthal J; Uzzan A; Conforti N
    Brain Res; 1986 Dec; 399(1):178-80. PubMed ID: 3492237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of 1-ethyl- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridines on catecholamine concentrations in mouse brain and heart.
    Fuller RW; Hemrick-Luecke SK; Robertson DW
    Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):129-32. PubMed ID: 3258433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphetamine, but not reserpine, protects mice against dopaminergic neurotoxicity of MPTP.
    Melamed E; Rosenthal J; Cohen O; Uzzan A; Globus M
    Neuropharmacology; 1985 Sep; 24(9):923-5. PubMed ID: 3877249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.